Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

638 recalls, newest first

Class II · Moderate risk

Mafenide Acetate

Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene

Terminated Particulate / foreign matter Par Pharmaceutical Inc. NDC 49884-902-52 D-0393-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-149-50 D-1828-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-236-50 D-1827-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-156-50 D-1826-2015
Class I · High risk

Fentanyl Citrate

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-107-50 D-1825-2015
Class I · High risk

Morphine Sulfate

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-181-50 D-1824-2015
Class I · High risk

Bupivacaine HCl 0.0625%

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-197-50 D-1823-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-169-50 D-1822-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-171-50 D-1821-2015
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-0381-2015
Class I · High risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0553-18 D-481-2015
Class II · Moderate risk

HydrALAZINE Hydrochloride Tablets

Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.

Terminated Particulate / foreign matter Par Pharmaceutical Inc. D-0332-2015
Class I · High risk

1% LIDOCAINE HCl Injection

Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0391-2015
Class III · Low risk

BENZONATATE Capsules

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc D-0289-2015
Class I · High risk

Heparin Sodium

Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-7620-03 D-0324-2015
Class II · Moderate risk

Bupivacaine HCl Inj.

Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1162-02 D-1588-2014
Class I · High risk

CUBICIN (daptomycin for injection)

Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.

Terminated Particulate / foreign matter Cubist Pharmaceuticals, Inc. NDC 67919-011-01 D-0229-2015
Class I · High risk

Dianeal Low Calcium

Presence of Particulate Matter: particulate matter was found during the manufacturing process.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0941-0457-05 D-1610-2014

Recalls by year